• Users Online: 279
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2020  |  Volume : 8  |  Issue : 1  |  Page : 21-28

Comparative study of Lodhradi Lepa with and without Arogyavardhini Vati in the management of Yuvanpidika


1 Department of Kayachikitsa, ASPM Ayurved Medical College, Buldhana, India
2 Department of Swasthavritta, Mahatma Gandhi Ayurved College Hospital and Research Centre, Datta Meghe Institute of Medical Sciences (DU), Wardha, Maharashtra, India

Correspondence Address:
Sadhana D Misar Wajpeyi
Department of Swasthavritta, Mahatma Gandhi Ayurved College Hospital and Research Centre, Datta Meghe Institute of Medical Sciences (DU), Wardha, Maharashtra.
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/JISM.JISM_20_20

Rights and Permissions

Background: Yuvanpidika can be correlated with acne vulgaris of modern medicine due to the resemblance of symptoms. It is not a serious health problem, but it affects the social and emotional health of an individual. It is self-limiting but requires treatment to avoid scarring and relapse. Aim and Objectives: This comparative research was carried out with the aim to evaluate the efficacy of Lodhradi Lepa with and without Arogyavardhini Vati in the management of Yuvanpidika. Materials and Methods: A total of 30 patients between the ages of 16 and 36 years of both sexes with typical symptoms of Yuvanpidika were selected from Kayachikitsa outpatient department. They were divided equally into two groups by lottery method. Lodhradi Lepa was topically applied with rose water to patients in Group A twice daily, whereas Group B was given Arogyavardhini Vati (500mg) twice a day along with Lodhradi Lepa for 30 days. Pain, itching, burning sensation, swelling, redness, and the number of papules were assessed before and after treatment in both groups. Results: In this study, moderate, mild, and poor improvements were observed in five (33.33%), two (13.33%), and eight (53.33%) patients of Group A, respectively, whereas in Group B, moderate, mild, and poor improvements were observed in eight (53.33%), four (26.66%), and three (20%) patients, respectively. Marked improvement and complete remission were not observed in this study. This might be due to a short duration of treatment. Conclusion: This study proved that the use of Lodhradi Lepa and Arogyavardhini Vati is effective in the treatment of Yuvanpidika. But combined treatment is more beneficial and combination of various protocols and formulations need to be adopted for better results.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed188    
    Printed10    
    Emailed0    
    PDF Downloaded38    
    Comments [Add]    

Recommend this journal